Puma Biotechnology to Present at the B. Riley Oncology Investor Conference

LOS ANGELES–(BUSINESS WIRE)–Alan Auerbach, CEO and President of Puma Biotechnology, will present a company update at the B. Riley Oncology Investor Conference on Jan. 21.